Solarvest BioEnergy Inc. Acquires Algae Production Facility

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company"),
wishes to announce Solarvest has made significant progress in its plans to use
its patented algal technology to develop commercial products focused on health
care. The Company recently completed negotiations to acquire a 30,000 sq. ft.
facility in Summerville Prince Edward Island which will be repurposed to house
the Company's planned algal production. Solarvest has acquired the facility on a
lease to own basis for $436,000 with an 8-year term, the previous owner had
invested in excess of $2.2 million in developing the facility.


Originally designed as a yeast production facility it is uniquely suited for
algae with only minimal reconfiguration. There is also a significant amount of
equipment in place which can be used to enhance the Company's research and
development laboratories which will be relocated to the facility. The new
facility is sufficient size to support up to 10,000 tons of annual production
and 6.5 hectares of land, allowing for future expansion.


Solarvest expects the planned renovation will be completed in the second quarter
of 2013 with pilot production to begin mid to late 2013. The initial commercial
nutraceutical products will be produced from algae strains that are generating
high levels of Omega-3 DHA/EPA. The Company has successfully produced laboratory
scale batches and is now in a position to scale up production from pilot batch
to commercial production.


The market for Omega 3's is currently $13 billon and forecast to grow to $15
billion by 2015. Scientific research supports the proposition that the
consumption of omega-3 fatty acids containing DHA and EPA may help to sustain
cardiovascular health and brain function and may reduce the symptoms of some
inflammatory conditions. Currently the primary source of Omega 3's is fish oil,
which has limitations, not the least of which, is contamination with heavy
metals, dioxin and PCB's in addition to being unsustainable.


Solarvest has developed algae strains rich in DHA/EPA that can be produced
sustainably, economically, and extracted without solvents, harsh chemicals and
most importantly, from a consumer acceptance viewpoint, without a strong
unpleasant fishy flavor.


About Solarvest BioEnergy:

Solarvest BioEnergy Inc. is a world leading algae technology company that
commercializes proprietary and advanced products for substantial markets. The
Company's algal based production platform provided it with an extremely flexible
system capable of being adapted to produce both human and animal health products
in an economic and environmentally sensitive manner.


The statements made in this news release may contain forward-looking statements
that may involve a number of risks and uncertainties. Actual events or results
could differ materially from the Company's expectations and projections.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Solarvest BioEnergy Inc.
Gerri Greenham
Chief Executive Officer
416 420 0947
ggreenham@solarvest.ca
www.solarvest.ca

Solarvest BioEnergy (TSXV:SVS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024